Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Oestrogen receptor α gene expression levels are reduced in obese compared to normal weight females

Abstract

Objective:

To determine whether oestrogen receptor (ER)α messenger RNA (mRNA) levels or single nucleotide polymorphisms (SNPs) are associated with obesity in Swedish women.

Design:

ERα mRNA expression levels were measured by real-time qPCR in subcutaneous adipose tissue from non-obese (N=16, BMI <30) and obese (N=17, BMI 30) women. In addition, ERα mRNA expression levels were determined in isolated adipocytes. ERα promoter usage was characterized by 5′ RACE and by real-time qPCR in subcutaneous adipose tissue from the same non-obese and obese women. Two ERα SNPs were scored in 509 non-obese and 489 obese females.

Results:

ERα mRNA expression levels were lower in obese compared to non-obese women in both subcutaneous adipose tissue and in adipocytes. We show that two ERα promoters are differentially utilized in obese and non-obese individuals. We did not find any significant association between obesity and the ERα SNPs or haplotypes assayed.

Conclusion:

The reduced ERα mRNA levels observed in adipose tissue from obese compared to non-obese women support a role for oestrogen signaling via ERα, in control of body weight. Mechanistic studies of the role of ERα in adipocytes and how its expression is regulated in relation to fat mass should be performed. The latter studies should focus on the two promoters that are used differently in obese and non-obese individuals.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Comuzzie AG, Williams JT, Martin LJ, Blangero J . Searching for genes underlying normal variation in human adiposity. J Mol Med 2001; 79: 57–70.

    Article  CAS  Google Scholar 

  2. Clement K . Genetics of human obesity. Proc Nutr Soc 2005; 64: 133–142.

    Article  CAS  Google Scholar 

  3. Matthews J, Gustafsson JA . Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Intervent 2003; 3: 281–292.

    Article  CAS  Google Scholar 

  4. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986; 320: 134–139.

    Article  CAS  Google Scholar 

  5. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J . Sequence and expression of human estrogen receptor complementary DNA. Science 1986; 231: 1150–1154.

    Article  CAS  Google Scholar 

  6. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA . Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925–5930.

    Article  CAS  Google Scholar 

  7. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G et al. Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J 2000; 19: 4688–4700.

    Article  CAS  Google Scholar 

  8. Dieudonne MN, Leneveu MC, Giudicelli Y, Pecquery R . Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol 2004; 286: C655–C661.

    Article  CAS  Google Scholar 

  9. Blumel JE, Castelo-Branco C, Rocangliolo ME, Bifa L, Tacla X, Mamani L . Changes in body mass index around menopause: a population study of Chilean woman. Menopause 2001; 8: 239–244.

    Article  CAS  Google Scholar 

  10. Lovejoy JC . The menopause and obesity. Prim Care 2003; 30: 317–325.

    Article  Google Scholar 

  11. Ozbey N, Sencer E, Molvalilar S, Orhan Y . Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocr J 2002; 49: 503–509.

    Article  Google Scholar 

  12. Dicker A, Ryden M, Naslund E, Muehlen IE, Wiren M, Lafontan M et al. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 2004; 47: 420–428.

    Article  CAS  Google Scholar 

  13. Haarbo J, Marslew U, Gotfredsen A, Christiansen C . Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40: 1323–1326.

    Article  CAS  Google Scholar 

  14. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997; 82: 414–417.

    Article  CAS  Google Scholar 

  15. Reubinoff BE, Wurtman J, Rojansky N, Adler D, Stein P, Schenker JG et al. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril 1995; 64: 963–968.

    Article  CAS  Google Scholar 

  16. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523–534.

    Article  CAS  Google Scholar 

  17. Sites CK, L'Hommedieu GD, Toth MJ, Brochu M, Cooper BC, Fairhurst PA . The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005; 90: 2701–2707.

    Article  CAS  Google Scholar 

  18. Couse JF, Korach KS . Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999; 20: 358–417.

    Article  CAS  Google Scholar 

  19. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998; 95: 15677–15682.

    Article  CAS  Google Scholar 

  20. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O . Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993; 90: 11162–11166.

    Article  CAS  Google Scholar 

  21. Atwood LD, Heard-Costa NL, Cupples LA, Jaquish CE, Wilson PW, D'Agostino RB . Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study. Am J Hum Genet 2002; 71: 1044–1050.

    Article  CAS  Google Scholar 

  22. Fox CS, Heard-Costa NL, Wilson PW, Levy D, D’Agostino RB, Atwood Sr LD . Genome-wide linkage to chromosome 6 for waist circumference in the Framingham Heart Study. Diabetes 2004; 53: 1399–1402.

    Article  CAS  Google Scholar 

  23. Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H . Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord 2003; 27: 1020–1027.

    Article  CAS  Google Scholar 

  24. Fox CS, Yang Q, Cupples LA, Guo CY, Atwood LD, Murabito JM et al. Sex-specific association between estrogen receptor-alpha gene variation and measures of adiposity: the Framingham Heart Study. J Clin Endocrinol Metab 2005; 90: 6257–6262.

    Article  CAS  Google Scholar 

  25. Lofgren P, Hoffstedt J, Ryden M, Thorne A, Holm C, Wahrenberg H et al. Major gender differences in the lipolytic capacity of abdominal subcutaneous fat cells in obesity observed before and after long-term weight reduction. J Clin Endocrinol Metab 2002; 87: 764–771.

    Article  CAS  Google Scholar 

  26. Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P . Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 1998; 41: 65–71.

    Article  CAS  Google Scholar 

  27. Hoffstedt J, Arvidsson E, Sjolin E, Wahlen K, Arner P . Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 2004; 89: 1391–1396.

    Article  CAS  Google Scholar 

  28. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63.

    Article  CAS  Google Scholar 

  29. Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P . Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia 1994; 37: 428–435.

    Article  CAS  Google Scholar 

  30. Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P . Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 2004; 53: 1966–1971.

    Article  CAS  Google Scholar 

  31. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056–1061.

    Article  CAS  Google Scholar 

  32. Dahlman I, Eriksson P, Kaaman M, Jiao H, Lindgren CM, Kere J et al. alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 2004; 47: 1974–1979.

    Article  CAS  Google Scholar 

  33. Kos M, Reid G, Denger S, Gannon F . Minireview: genomic organization of the human ERalpha gene promoter region. Mol Endocrinol 2001; 15: 2057–2063.

    CAS  PubMed  Google Scholar 

  34. Okuda Y, Hirata S, Watanabe N, Shoda T, Kato J, Hoshi K . Novel splicing events of untranslated first exons in human estrogen receptor alpha (ER alpha) gene. Endocr J 2003; 50: 97–104.

    Article  CAS  Google Scholar 

  35. Dahlman I, Linder K, Arvidsson Nordstrom E, Andersson I, Liden J, Verdich C et al. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 2005; 81: 1275–1285.

    Article  CAS  Google Scholar 

  36. Gallicchio L, Visvanathan K, Miller SR, Babus J, Lewis LM, Zacur H et al. Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol 2005; 193: 1353–1360.

    Article  CAS  Google Scholar 

  37. Olson MB, Shaw LJ, Kaizar EE, Kelsey SF, Bittner V, Reis SE et al. Obesity distribution and reproductive hormone levels in women: A Report from the NHLBI-Sponsored WISE Study. J Womens Health (Larchmt) 2006; 15: 836–842.

    Article  Google Scholar 

Download references

Acknowledgements

We thank all subjects for participating in the present study. This work was supported by The Royal Physiographic Society in Lund, Stiftelsen Goljes Minne, Stiftelsen Lars Hiertas Minne (all to MN) and the EU NoE CASCADE. The authors want to thank Patricia Humire, Eva Sjölin, Lise-Lotte Vedin and Kerstin Wåhlén for technical assistance. The authors are also greatful to Professor Anthony Wright and Doctor Knut Steffensen for critical comments on the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Nilsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilsson, M., Dahlman, I., Rydén, M. et al. Oestrogen receptor α gene expression levels are reduced in obese compared to normal weight females. Int J Obes 31, 900–907 (2007). https://doi.org/10.1038/sj.ijo.0803528

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803528

Keywords

This article is cited by

Search

Quick links